Osteopontin regulates anabolic effect in human menopausal osteoporosis with intermittent parathyroid hormone treatment

Osteoporosis International

Volumn 22, Issue 2, 2011, Pages 577-585

  Chiang, T I ^a,b   Chang, I C ^a,b   Lee, H S ^a   Lee, H ^a,c   Huang, C H ^a   Cheng, Y W ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Bone mineral density; Osteopontin; Osteoporosis; Parathyroid hormone

Indexed keywords

C REACTIVE PROTEIN; CALCIUM CARBONATE; OSTEOPONTIN; PARATHYROID HORMONE[1-34];

ADULT; AGED; ARTICLE; BONE DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE MARKER; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE OVEREXPRESSION; HIP; HIP FRACTURE; HORMONAL THERAPY; HORMONE SYNTHESIS; HUMAN; LUMBAR SPINE; OSTEOLYSIS; PILOT STUDY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SCORING SYSTEM; T SCORE; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE; VERTEBRA FRACTURE; Z SCORE;

ABSORPTIOMETRY, PHOTON; AGED; AGED, 80 AND OVER; BONE DENSITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIP; HUMANS; LUMBAR VERTEBRAE; OSTEOPONTIN; OSTEOPOROSIS, POSTMENOPAUSAL; PARATHYROID HORMONE; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 78651492544     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-010-1327-x     Document Type: Article

References (55)

1. M Ishijima Y Ezura T Kunikazu SR Rittling H Kurosawa DT Denhardt M Emi A Nifuji M Noda 2006 Osteopontin during tail-suspension-induced bone loss Exp Cell Res 312 3075 3083 1:CAS:528:DC%2BD28XptFSqtbc%3D 10.1016/j.yexcr.2006.06.003 16889770
2. CJ Rosen JP Bilezikian 2001 Clinical review 123: anabolic therapy for osteoporosis J Clin Endocrinol Metab 86 957 964 1:CAS:528:DC%2BD3MXitFWns74%3D 10.1210/jc.86.3.957 11238469
3. E Seeman PD Delmas 2001 Reconstructing the skeletion with intermittent parathyroid hormone Trends Endocrinol Metab 12 281 283 1:CAS:528: DC%2BD3MXlvFWlsbo%3D 10.1016/S1043-2760(01)00460-X 11504661
4. J Fox MA Miller MK Newman AF Metcalfe CH Turner RR Recker SY Smith 2006 Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength Calcif Tissue Int 79 4 262 272 1:CAS:528:DC%2BD28XhtFGjs7%2FK 10.1007/s00223-006-0108-1 16969596
5. RR Recker SP Bare SY Smith A Varela MA Miller SA Morris J Fox 2008 Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84 Bone 44 1 113 119 10.1016/j.bone.2008.09.019 18983947
6. F Cosman 2008 Parathyroid hormone treatment for osteoporosis Curr Opin Endocrinol Diabetes Obes 15 6 495 501 1:CAS:528:DC%2BD1cXhtlSgsrfP 18971677
7. S Nomura T Takano-Yamamoto 2000 Molecular events caused by mechanical stress in bone Matrix Biol 19 2 91 96 1:CAS:528:DC%2BD3cXkt1aqurc%3D 10.1016/S0945-053X(00)00050-0 10842092
8. K Kitahara M Ishijima SR Rittling K Tsuji H Kurosawa A Nifuji DT Denhardt M Noda 2003 Osteopontin deficiency induces parathyroid hormone enhancement of cortical bone formation Endocrinology 144 5 2132 2140 1:CAS:528: DC%2BD3sXjt1Wit7o%3D 10.1210/en.2002-220996 12697722
9. SR Rittling HN Matsumoto MD Mckee A Nanci XR An KE Novick AJ Kowalski M Noda DT Denhardt 1998 Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro J Bone Miner Res 13 1101 1111 1:CAS:528:DyaK1cXks1arsr8%3D 10.1359/jbmr.1998.13.7.1101 9661074
10. SR Rittling DT Denhardt 1999 Osteopontin function in pathology: lessons from osteopontin-deficient mice Exp Nephrol 7 103 113 1:CAS:528: DyaK1MXjtVSju7k%3D 10.1159/000020591 10213864
11. H Yoshitake SR Rittling DT Denhardt M Noda 1999 Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption Proc Natl Acad Sci USA 96 8156 8160 1:CAS:528:DyaK1MXltVOrsL8%3D 10.1073/pnas.96.14.8156 10393964
12. Y Asou SR Rittling H Yoshitake K Tsuji K Shinomiya A Nifuji DT Denhardt M Noda 2001 Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone Endocrinology 142 1325 1332 1:CAS:528: DC%2BD3MXhsFemtbg%3D 10.1210/en.142.3.1325 11181551
13. H Ihara DT Denhardt K Furuya T Yamashita Y Muguruma K Tsuji KA Hruska K Higashio S Enomoto A Nifuji SR Rittling M Noda 2001 Parathyroid hormone-induced bone resorption does not occur in the absence of osteopontin J Biol Chem 276 13065 13071 1:CAS:528:DC%2BD3MXjtFyms7c%3D 10.1074/jbc.M010938200 11278791
14. K Yumoto M Ishijima SR Rittling K Tsuji Y Tsuchiya S Kon A Nifuji T Uede DT Denhardt M Noda 2002 Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice Proc Natl Acad Sci USA 99 4556 4561 1:CAS:528:DC%2BD38XivFShurk%3D 10.1073/pnas.052523599 11930008
15. M Morinobu M Ishijima SR Rittling K Tsuji H Yamamoto A Nifuji DT Denhardt M Noda 2003 Osteopontin expression in osteoblasts and osteocytes during bone formation under mechanical stress in the calvarial suture in vivo J Bone Miner Res 18 1706 1715 1:CAS:528:DC%2BD3sXnsVymu7k%3D 10.1359/jbmr.2003.18.9.1706 12968681
16. Y Chen BS Bal JP Gorski 1992 Calcium and collagen binding properties of osteopontin, bone sialoprotein, and bone acidic glycoprotein-75 from bone J Boil Chem 267 24871 24878 1:CAS:528:DyaK38XmtVOntLk%3D
17. JR Hoyer L Otvos Jr L Urge 1995 Osteopontin in urinary stone formation Ann N Y Acad Sci 760 257 265 1:CAS:528:DyaK2MXovVSitrc%3D 10.1111/j.1749-6632. 1995.tb44636.x 7785900
18. RL MacNeli J Berry SC D'ErricoJ B Piotrowski MJ Somerman 1995 Role of two mineral-associated adhesion molecules, osteopontin and bone sialoprotein, during cementogenesis Connect Tissue Res 33 1 7 10.3109/03008209509016974
19. MA Horton MA Nesbit MH Helfrich 1995 Interaction of osteopontin with osteoclast integrins Ann N Y Acad Sci 760 190 200 1:CAS:528:DyaK2MXovVSitr0%3D 10.1111/j.1749-6632.1995.tb44630.x 7540373
20. CM Giachelli L Liaw CE Murry S Schwartz MM Almeida 1995 Osteopontin expression in cardiovascular diseases Ann N Y Acad Sci 760 109 126 1:CAS:528:DyaK2MXovVSisbk%3D 10.1111/j.1749-6632.1995.tb44624.x 7785890
21. L Liaw DM Lombardi MM Almeida SM Schwartz D DeBlois CM Giachelli 1997 Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation Arterioscler Thromb Vasc Biol 17 188 193 1:CAS:528:DyaK2sXhtFGmsr0%3D 9012655
22. R Pichler CM Giachelli B Young CE Alpers WG Couser RJ Johnson 1995 The pathogenesis of tubulointerstitial disease associated with glomerulonephritis: the glomerular cytokine theory Miner Electrolyte Metab 21 317 327 1:CAS:528:DyaK2MXntlChtLg%3D 7565480
23. DR Senger LF Brown CA Perruzzi A Papadopoulos-Sergiou L Van de Water 1995 Osteopontin at the tumor/host interface. Functional regulation by thrombin-cleavage and consequences for cell adhesion Ann N Y Acad Sci 760 83 100 1:CAS:528:DyaK2MXovVSisbs%3D 10.1111/j.1749-6632.1995.tb44622.x 7540380
24. GF Weber S Ashkar MJ Glimcher H Cantor 1996 Receptor-ligand interaction between CD44 and osteopontin (Eta-1) Science 271 509 512 1:CAS:528: DyaK28XmvFyrtA%3D%3D 10.1126/science.271.5248.509 8560266
25. OD Kennedy O Brennan SM Rackard A Staines FJ O'Brien D Taylor TC Lee 2009 Effects of ovariectomy on bone turnover, porosity, and biomechanical properties in ovine compact bone 12 months postsurgery J Orthop Res 27 303 309 10.1002/jor.20750 18853433
26. SA Shapses M Cifuentes L Spevak H Chowdhury J Brittingham AL Boskey DT Denhardt 2003 Osteopontin facilitates bone resorption, decreasing bone mineral crystallinity and content during calcium deficiency Calcif Tissue Int 73 1 86 92 1:CAS:528:DC%2BD3sXmsFGltbg%3D 10.1007/s00223-002-1090-x 14506959
27. M Ishijima K Tsuji SR Rittling T Yamashita H Kurosawa DT Denhardt A Nifuji Y Ezura M Noda 2007 Osteopontin is required for mechanical stress-dependent signals to bone marrow cells J Endocrinol 193 2 235 243 1:CAS:528:DC%2BD2sXlvFKkur0%3D 10.1677/joe.1.06704 17470514
28. NB Kavukcuoglu DT Denhardt N Guzelsu AB Mann 2007 Osteopontin deficiency and aging on nanomechanics of mouse bone J Biomed Mater Res A 83 1 136 144 17390367
29. RM McCann G Colleary C Geddis SA Clarke GR Jordan GR Dickson D Marsh 2008 Effect of osteoporosis on bone mineral density and fracture repair in a rat femoral fracture model J Orthop Res 26 384 393 10.1002/jor.20505 17960650
30. L Malaval NM Wade-Guéye M Boudiffa J Fei R Zirngibl F Chen N Laroche JP Roux B Burt-Pichat F Duboeuf G Boivin P Jurdic MH Lafage-Proust J Amédée L Vico J Rossant JE Aubin 2008 Bone sialoprotein plays a functional role in bone formation and osteoclastogenesis J Exp Med 205 5 1145 1153 1:CAS:528:DC%2BD1cXlvFWrs7g%3D 10.1084/jem.20071294 18458111
31. H Yamane A Sakai T Mori S Tanaka K Moridera T Nakamura 2009 The anabolic action of intermittent PTH in combination with cathepsin K inhibitor or alendronate differs depending on the remodeling status in bone in ovariectomized mice Bone 44 6 1055 1062 1:CAS:528:DC%2BD1MXlslWisr0%3D 10.1016/j.bone.2008.05. 010 19303837
32. N Ono K Nakashima SR Rittling E Schipani T Hayata K Soma DT Denhardt HM Kronenberg Y Ezura M Noda 2008 Osteopontin negatively regulates parathyroid hormone receptor signaling in osteoblasts J Biol Chem 283 28 19400 19409 1:CAS:528:DC%2BD1cXotF2ksL0%3D 10.1074/jbc.M800005200 18417476
33. SA Steitz MY Speer MD McKee L Liaw M Almeida H Yang CM Giachelli 2002 Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification Am J Pathol 161 6 2035 2046 1:CAS:528:DC%2BD38Xpslemur8%3D 12466120
34. Chang IC, Chiang TY, Yah KT, Lee H, Cheng YW (2010) Increased serum osteopontin is a risk factor for osteoporosis in menopausal women. Osteoporosis Int (in press)
35. M Wallace M Shelkey 2008 Katz index of independence in activities of daily living Assisted Living Consult 14 21 22
36. D Vordermark HM Said A Katzer T Kuhnt G Hänsgen J Dunst M Flentje M Bache 2006 Plasma osteopontin levels in patients with head and neck cancer and cervix cancer are critically dependent on the choice of ELISA system BMC Cancer 6 207 10.1186/1471-2407-6-207 16911785
37. T Ishii S Ohshima T Ishida T Mima Y Tabunoki H Kobayashi M Maeda T Uede L Liaw N Kinoshita I Kawase Y Saeki 2004 Osteopontin as a positive regulator in the osteoclastogenesis of arthritis Biochem Biophys Res Commun 316 3 809 815 1:CAS:528:DC%2BD2cXitFKgsbk%3D 10.1016/j.bbrc.2004.02.124 15033472
38. T Sugatani U Alvarez KA Hruska 2003 PTEN regulates RANKL- and osteopontin-stimulated signal transduction during osteoclast differentiation and cell motility J Biol Chem 278 7 5001 5008 1:CAS:528:DC%2BD3sXhtVKltrs%3D 10.1074/jbc.M209299200 12460992
39. CG Walker Y Ito S Dangaria X Luan TG Diekwisch 2008 RANKL, osteopontin, and osteoclast homeostasis in a hyperocclusion mouse model Eur J Oral Sci 116 4 312 8 10.1111/j.1600-0722.2008.00545.x 18705798
40. Eastell R (2003) Pathogenesis of postmenopausal osteoporosis. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 5th edn. American Society for Bone and Mineral Research, Washington DC, pp 314-316
41. R Recker J Lappe K Davies R Heaney 2000 Characterization of perimenopausal bone loss: a prospective study J Bone Miner Res 15 1965 1973 1:STN:280:DC%2BD3cvnslSkuw%3D%3D 10.1359/jbmr.2000.15.10.1965 11028449
42. B Abrahamsen N Nissen AP Hermann B Hansen O Bärenholdt P Vestergaard CL Tofteng S Pors Nielsen 2002 When should densitometry be repeated in healthy peri- and postmenopausal women?: the Danish osteoporosis prevention study J Bone Miner Res 17 2061 2067 1:STN:280:DC%2BD38nltFGmtA%3D%3D 10.1359/jbmr.2002.17. 11.2061 12412814
43. Y Li A Li X Yang MN Weitzmann 2007 Ovariectomy-induced bone loss occurs independently of B cells J Cell Biochem 100 6 1370 1375 1:CAS:528: DC%2BD2sXjvVSlsbc%3D 10.1002/jcb.21121 17131364
44. MC Bezerra JF Carvalho AS Prokopowitsch RM Pereira 2005 RANK, RANKL and osteoprotegerin in arthritic bone loss Braz J Med Biol Res 38 2 161 170 1:CAS:528:DC%2BD2MXjtVOmsL8%3D 10.1590/S0100-879X2005000200004 15785827
45. SN Somayaji S Ritchie M Sahraei I Marriott MC Hudson 2008 Staphylococcus aureus induces expression of receptor activator of NF-kappaB ligand and prostaglandin E2 in infected murine osteoblasts Infect Immun 76 11 5120 5126 1:CAS:528:DC%2BD1cXhtlajtrbN 10.1128/IAI.00228-08 18765718
46. S Oh TW Kyung HS Choi 2008 Curcumin inhibits osteoclastogenesis by decreasing receptor activator of nuclear factor-kappaB ligand (RANKL) in bone marrow stromal cells Mol Cells 26 5 486 489 1:CAS:528:DC%2BD1cXhsFemtLnJ 18719352
47. D Seriwatanachai K Thongchote N Charoenphandhu J Pandaranandaka K Tudpor J Teerapornpuntakit T Suthiphongchai N Krishnamra 2008 Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio Bone 42 3 535 546 1:CAS:528:DC%2BD1cXitVOmurs%3D 10.1016/j.bone.2007.11.008 18166509
48. DD Pierroz A Rufo EN Bianchi V Glatt M Capulli N Rucci F Cavat R Rizzoli A Teti ML Bouxsein SL Ferrari 2009 Beta-Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice J Bone Miner Res 24 5 775 784 1:CAS:528:DC%2BD1MXlvVWhtLY%3D 10.1359/jbmr.081237 19113915
49. DT Denhardt M Noda AW O'Regan D Pavlin JS Berman 2001 Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival J Clin Investig 107 1055 1061 1:CAS:528: DC%2BD3MXjsVCjtL0%3D 10.1172/JCI12980 11342566
50. R Zohar N Suzuki K Suzuki P Arora M Glogauer CA McCulloch J Sodek 2000 Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration J Cell Physiol 184 118 130 1:CAS:528: DC%2BD3cXjvFynu7w%3D 10.1002/(SICI)1097-4652(200007)184:1<118::AID- JCP13>3.0.CO;2-Y 10825241
51. YH Lin HF Yang-Yen 2001 The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3-kinase/Akt signaling pathway J Biol Chem 276 46024 46030 1:CAS:528:DC%2BD3MXptVymsb8%3D 10.1074/jbc.M105132200 11590166
52. SL Cheng CF Lai SD Blystone LV Avioli 2001 Bone mineralization and osteoblast differentiation are negatively modulated by integrin alpha(v)beta3 J Bone Miner Res 16 2 277 88 1:CAS:528:DC%2BD3MXptlOqsQ%3D%3D 10.1359/jbmr.2001. 16.2.277 11204428
53. RL Jilka RS Weinstein T Bellido P Roberson AM Parfitt SC Manolagas 1999 Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone J Clin Invest 104 4 439 446 1:CAS:528:DyaK1MXltlekur8%3D 10.1172/JCI6610 10449436
54. AB Hodsman LJ Fraher T Ostbye JD Adachi BM Steer 1993 An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis J Clin Invest 91 3 1138 1148 1:CAS:528:DyaK3sXitVGlu7c%3D 10.1172/JCI116273 8450043
55. A Iida-Klein H Zhou SS Lu LR Levine M Ducayen-Knowles DW Dempster J Nieves R Lindsay 2002 Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice J Bone Miner Res 17 5 808 16 1:CAS:528:DC%2BD38XktVSktr0%3D 10.1359/jbmr.2002.17.5.808 12009011